A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Seagen Inc.
Novartis
Eli Lilly and Company
Pfizer
Ohio State University Comprehensive Cancer Center
Pfizer
Pfizer
Eli Lilly and Company
City of Hope Medical Center
Enliven Therapeutics
Cancer Trials Ireland
University Health Network, Toronto
City of Hope Medical Center
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Tanta University
Hansoh BioMedical R&D Company
Ohio State University Comprehensive Cancer Center
Merck Sharp & Dohme LLC
Eli Lilly and Company
Ono Pharmaceutical Co. Ltd
Servier
Shanghai Zhongshan Hospital
Canadian Cancer Trials Group
Barbara Ann Karmanos Cancer Institute
Institut du Cancer de Montpellier - Val d'Aurelle
Ludwig Institute for Cancer Research
NSABP Foundation Inc
University of Massachusetts, Worcester
GSO Global Clinical Research BV
University of Utah
Gilead Sciences
TG Therapeutics, Inc.
M.D. Anderson Cancer Center
mAbxience Research S.L.
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
GlaxoSmithKline
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
National Cancer Centre, Singapore
Hoffmann-La Roche
Duke University
UNC Lineberger Comprehensive Cancer Center